U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H23O3S.Na
Molecular Weight 342.428
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM DIBUNATE

SMILES

[Na+].CC(C)(C)C1=CC2=C(C=C1)C(=C(C=C2)C(C)(C)C)S([O-])(=O)=O

InChI

InChIKey=XYEXKDCAGSHWSD-UHFFFAOYSA-M
InChI=1S/C18H24O3S.Na/c1-17(2,3)13-8-9-14-12(11-13)7-10-15(18(4,5)6)16(14)22(19,20)21;/h7-11H,1-6H3,(H,19,20,21);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula C18H23O3S
Molecular Weight 319.438
Charge -1
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Dibunate (also known as Becantex, Becantyl, Linctussal, L-1633, and described as the 2,6-isomer or the 2,7-isomer) is an antitussive oral medication that was used in many counties all over the world. The current marketing status of the drug is unknown and is supposed to be "discontinued".

Originator

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
BECANTEX

Sample Use Guides

In Vivo Use Guide
1 tablet (30 mg) 3-4 times per day.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
FRS4SO3K8D
Record Status Validated (UNII)
Record Version